It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study investigated for the first time a simple bio-synthesis approach for the synthesis of copper oxide nanoparticles (CuO NPs) using Annona muricata L (A. muricata) plant extract to test their anti-cancer effects. The presence of CuONPs was confirmed by UV–visible spectroscopy, Scanning electron microscope (SEM), and Transmission electron microscope (TEM). The antiproliferative properties of the synthesized nanoparticles were evaluated against (AMJ-13), (MCF-7) breast cancer cell lines, and the human breast epithelial cell line (HBL-100) as healthy cells. This study indicates that CuONPs reduced cell proliferation for AMJ-13 and MCF-7. HBL-100 cells were not significantly inhibited for several concentration levels or test periods. The outcomes suggest that the prepared copper oxide nanoparticles acted against the growth of specific cell lines observed in breast cancer. It was observed that cancer cells had minor colony creation after 24 h sustained CuONPs exposure using (IC50) concentration for AMJ-13 was (17.04 µg mL−1). While for MCF-7 cells was (18.92 µg mL−1). It indicates the uptake of CuONPs by cancer cells, triggering apoptosis. Moreover, treatment with CuONPs enhanced Lactate dehydrogenase (LDH) production, probably caused by cell membrane damage, creating leaks comprising cellular substances like lactate dehydrogenase. Hence, research results suggested that the synthesized CuONPs precipitated anti-proliferative effects by triggering cell death through apoptosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Al-Nahrain University, Department of Biomedical Engineering, College of Engineering, Baghdad, Iraq (GRID:grid.411310.6) (ISNI:0000 0004 0636 1464)
2 Mustansiriyah University, Department of Biology, College of Science, Baghdad, Iraq (GRID:grid.411309.e) (ISNI:0000 0004 1765 131X)
3 University of Baghdad, Al_kindy College of Medicine, Baghdad, Iraq (GRID:grid.411498.1) (ISNI:0000 0001 2108 8169)
4 University of Misan, Department of Chemistry, College of Science, Maysan, Iraq (GRID:grid.449919.8) (ISNI:0000 0004 1788 7058); University of Warith Al-Anbiyaa, College of Medicine, Karbala, Iraq (GRID:grid.513648.d) (ISNI:0000 0004 7642 4328)
5 University of Baghdad, Department of Orthodontics, College of Dentistry, Baghdad, Iraq (GRID:grid.411498.1) (ISNI:0000 0001 2108 8169)
6 Al-Farahidi University, College of Dentistry, Baghdad, Iraq (GRID:grid.411498.1)
7 University of Technology, Department of Applied Sciences, Baghdad, Iraq (GRID:grid.444967.c) (ISNI:0000 0004 0618 8761)
8 Department of Medical Physics, Al-Mustaqbal University College, Babylon, Iraq (GRID:grid.444967.c)
9 Taif University, Department of Biology, College of Science, Taif, Saudi Arabia (GRID:grid.412895.3) (ISNI:0000 0004 0419 5255)
10 University of Al-Qadisiyah, Department of Internal and Preventive Medicine, College of Veterinary Medicine, Al Diwaniyah, Iraq (GRID:grid.440842.e) (ISNI:0000 0004 7474 9217)